Ocuphire Pharma
OCUP
$1.67
Share price
-2.90%
Change (1 day)
-72.31%
Change (1 year)
Categories
P/S ratio for Ocuphire Pharma (OCUP)
P/S ratio as of May 2024 (TTM): 2.31
According to Ocuphire Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.31228. At the end of 2023 the company had a P/S ratio of 3.58.
P/S ratio history for Ocuphire Pharma from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.58 | 94.07% |
| 2022 | 1.84 | -98.46% |
| 2021 | 119 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.03 | -55.32% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 3,900.32% | 🇺🇸 USA |